PDB37 THE COST-EFFECTIVENESS OF SAXAGLIPTIN VERSUS NPH INSULIN IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS (T2DM) IN POLAND
Autor: | Kolasa, K, Niewada, M, Puelles Fernandez de Troconiz, J, Townsend, R, McEwan, P |
---|---|
Zdroj: | In Value in Health 2010 13(7):A290-A290 |
Databáze: | ScienceDirect |
Externí odkaz: |